secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELI LILLY & Co (LLY)
CIK:        0000059478
Form:       8-K
Filed at:   2022-05-06T23:59:59+00:00
Accession:  0000059478-22-000143
Event type: leadership
Sentiment:  positive
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eli Lilly elects Dr. Mary Lynne Hedley to board effective May 15, 2022
----------------------------------------------------------------------

- Dr. Mary Lynne Hedley elected to Lilly's Board of Directors, effective May 15, 2022.
- She will serve on the Science & Technology Committee and the Ethics and Compliance Committee.
- Hedley is a Senior Scientific Fellow at Broad Institute; previously co-founded TESARO (acquired by GSK) and served as President/COO.
- Board determined she is independent under NYSE standards and company guidelines.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/59478/000005947822000143/0000059478-22-000143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/59478/000005947822000143/lly-20220502.htm
  HTML page:      https://secwatch.observer/filing/0000059478-22-000143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer